Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot/Phase IIa Trial of ESN364 in Early Postmenopausal Women With Hot Flashes
2015-002578-20Phase 2Completed
- Sponsor
- Euroscreen
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fezolinetant in hot flash, sponsored by Euroscreen. Primary endpoints: Change in weekly Hot Flash Score from baseline to Week 12 and Pharmacokinetics of ESN364. Started Jul 2015; status: completed.
02
Drugs
fezolinetant
03
Conditions
hot flash
Beyond the preview
Go deeper on 2015-002578-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002578-20.